PTK2 and hepatocellular carcinoma: By comparing the degradation of FAK with FAK PROTAC and phosphorylation inhibitors, we found that FAK PROTAC effectively degraded FAK in HCC cells (p < 0.0001), while phosphorylation inhibitors did not significantly affect the expression of FAK or EMT markers.